½ÃÀ庸°í¼
»óÇ°ÄÚµå
1444870
¿¬Á¶Á÷ ¼öº¹ : ¼¼°è ½ÃÀå Á¡À¯À² ºÐ¼®, »ê¾÷ µ¿Çâ ¹× Åë°è, ¼ºÀå ¿¹Ãø(2024-2029³â)Global Soft Tissue Repair - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) |
¼¼°è ¿¬Á¶Á÷ ¼öº¹ ½ÃÀå ±Ô¸ð´Â 2024³â 147¾ï 8,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2029³â±îÁö 188¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£(2024-2029³â) µ¿¾È 4.93%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
COVID-19 ÆÒµ¥¹ÍÀº Ãʱ⿡´Â ºÀ¼â Á¦ÇÑÀ¸·Î ÀÎÇØ ¿¬Á¶Á÷ ¼öº¹ ½Ã¼ú Ƚ¼ö°¡ °¨¼ÒÇÏ¸é¼ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃƽÀ´Ï´Ù. ¿¹¸¦ µé¾î, PubMed CentralÀÌ 2021³â 3¿ù¿¡ ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, Æú¶õµå¿¡¼ ½Ç½ÃµÈ ¿¬±¸¿¡ µû¸£¸é, ÆÒµ¥¹ÍÀÌ ÆÒµ¥¹Í Ãʱ⿡ ½ÃÇàµÈ Ä¡°ú ¼öº¹ ½Ã¼úÀ» Æ÷ÇÔÇÑ Ä¡°ú ½Ã¼úÀÇ ¼ö¿¡ Å« ¿µÇâÀ» ¹ÌÄ£ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±×·¯³ª ÆÒµ¥¹ÍÀÌ ÁøÇàµÊ¿¡ µû¶ó ¿¬Á¶Á÷ ¼öº¹ ½Ã¼úÀÌ Á¤»óÀûÀ¸·Î ÀÌ·ç¾îÁö¸é¼ ½ÃÀå ¼ºÀåÀÌ °¡¼ÓȵǾú½À´Ï´Ù. ¿¹¸¦ µé¾î, PubMed CentralÀÌ 2022³â 11¿ù¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é, ÆÒµ¥¹Í ±â°£ µ¿¾È Á¤Çü¿Ü°ú ¼ö¼ú¿¡ ´ëÇÑ º¯°æ »çÇ×ÀÌ ½ÃÇàµÇ¾ú°í, ÆÒµ¥¹ÍÀÌ ÁøÁ¤µÈ ÈÄ À¯ÀÍÇÑ °ÍÀ¸·Î ¹àÇôÁ® ÀÇ·á Á¤Çü¿Ü°ú °ü¸®¸¦ ÃÖÀûÈÇϱâ À§ÇÑ Àå±âÀûÀÎ ÇØ°áÃ¥ÀÌ µÉ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù. °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±× °á°ú, ÆÒµ¥¹ÍÀº óÀ½¿¡ °ËÅä ÁßÀÎ ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÃÆÀ¸³ª, ÆÒµ¥¹ÍÀÌ Á¾·áµÈ ÇöÀç, ½ÃÀåÀº ¿¬±¸ ¿¹Ãø ±â°£ µ¿¾È ²ÙÁØÈ÷ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ºÆ÷Ã÷ °ü·Ã ºÎ»ó Áõ°¡, ¿Ü»ó »ç°Ç Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀ¸·Î ÀÎÇØ ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý·üÀÇ Áõ°¡´Â ¿¬Á¶Á÷ ¼öº¹ ÀýÂ÷ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ±â ¶§¹®¿¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, SpringerLink°¡ 2022³â 9¿ù¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ µû¸£¸é, 2022³â ij³ª´Ù¿¡¼ ½Ç½ÃµÈ ¿¬±¸¿¡ µû¸£¸é ij³ª´Ù °íµîÇб³¿¡¼ Ãæµ¹ ½ºÆ÷Ã÷ Âü°¡ÀÚÀÇ ºÎ»ó·üÀÌ ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ´Ù°í ÇÕ´Ï´Ù. ÀÌ ¿¬±¸¿¡ µû¸£¸é, ºÎ»ó ¹ß»ý·üÀº ·°ºñ¿¡¼ ¸Å³â Âü°¡ÀÚ 100¸í´ç 12.7°Ç, ¾ÆÀ̽ºÇÏÅ°¿¡¼ ¸Å³â Âü°¡ÀÚ 100¸í´ç 33.1°ÇÀÇ ºÎ»óÀ» ÀÔ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¸Ó¸® ºÎ»óÀÇ À¯º´·üÀº 33.3%¿´½À´Ï´Ù. ¼Õ¸ñÀ̳ª ¼Õ ºÎ»óÀÇ °æ¿ì 16.0%¿´½À´Ï´Ù. ¾î±ú ºÎ»óÀº 12.8%, ¹«¸ ºÎ»óÀº 12.8%¿´½À´Ï´Ù. ¹«¸ ºÎ»óÀÇ °æ¿ì 12.0%¿´½À´Ï´Ù.
¶ÇÇÑ, ¹Ì±¹ Á¤½Åº¸°ÇÀ§¿øȸ(National Mental Health Council)°¡ 2022³â 8¿ù ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, ¹Ì±¹ ¼ºÀÎ Àα¸ÀÇ 70%°¡ ÀÏ»ý¿¡ ÇÑ ¹ø ÀÌ»ó ¿Ü»ó¼º »ç°ÇÀ» °æÇèÇÑ °ÍÀ¸·Î Ãß»êµË´Ï´Ù. 2¾ï 2,340¸¸ ¸íÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡ ¹Ì±¹¿¡¼´Â ºÎ»ó °Ç¼ö°¡ ¸¹°í ¿¬ºÎ Á¶Á÷ º¹±¸ ÀýÂ÷°¡ ´õ ¸¹ÀÌ ¼öÇà µÉ ¼ö ÀÖ½À´Ï´Ù.
¶ÇÇÑ, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °³¹ß Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 8¿ù Orthopedic Implant Company´Â FDA ½ÂÀÎÀ» ¹ÞÀº DRPX ¼Õ¸ñ °ñÀý Ç÷¹ÀÌÆ®¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ Ç÷¹ÀÌÆ®´Â À¯Çü II ¾ç±Ø»êÈ Æ¼Å¸´½°ú ¿¬Á¶Á÷¿¡ ´ëÇÑ Ãæµ¹À» ÃÖ¼ÒÈÇÏ´Â ¾ãÀº Ç÷¹ÀÌÆ® ¹× ³ª»ç µðÀÚÀÎÀ¸·Î ¼³°èµÇ¾ú½À´Ï´Ù.
µû¶ó¼ ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý·ü Áõ°¡, ¿Ü»ó »ç°Ç Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ °³¹ß Áõ°¡¿Í °°Àº ¾Õ¼ ¾ð±Þ ÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ ÃËÁø µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ³ôÀº ¼ö¼ú ºñ¿ëÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀ» ¹æÇØ ÇÒ ¼ö ÀÖ½À´Ï´Ù.
Á¤Çü¿Ü°ú ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖ½À´Ï´Ù. Á¤Çü¿Ü°ú ºÎ¹®ÀÇ ¼ºÀåÀº ´ëºÎºÐ ½ÅÁ¦Ç°, ³ëÀÎ Àα¸ Áõ°¡, °üÀý ¿¬Á¶Á÷ ¼Õ»óÀ¸·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù.
PubMed CentralÀÌ 2022³â ¹ßÇ¥ÇÑ ³í¹®¿¡ µû¸£¸é, 2022³â º£ÀÌ¡ ¿Ã¸²ÇÈ ±â°£ µ¿¾È Áß±¹¿¡¼ ½Ç½ÃµÈ Á¶»ç¿¡ µû¸£¸é 91°³±¹¿¡¼ ¾à 2,897¸íÀÇ ¼±¼ö°¡ ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó°ú Áúº´À» °æÇèÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù°í ÇÕ´Ï´Ù. ¿Ã¸²ÇÈ ÀÇ·áÁøÀº 326°ÇÀÇ ºÎ»ó°ú 80°ÇÀÇ Áúº´À» º¸°íÇßÀ¸¸ç, ÀÌ´Â ¿Ã¸²ÇÈ ±â°£ 17ÀÏ µ¿¾È ¼±¼ö 100¸í´ç 11.3°ÇÀÇ ºÎ»ó°ú 2.8°ÇÀÇ Áúº´¿¡ ÇØ´çÇÕ´Ï´Ù. ÀüüÀûÀ¸·Î ¼±¼öÀÇ 11%°¡ Àû¾îµµ ÇÑ °¡Áö ÀÌ»óÀÇ ºÎ»óÀ» ÀÔ¾ú°í, ¾à 3%°¡ Àû¾îµµ ÇÑ °¡Áö ÀÌ»óÀÇ Áúº´À» °æÇèÇß½À´Ï´Ù. µû¶ó¼ ½ºÆ÷Ã÷ ºÎ»óÀÇ ³ôÀº À¯º´·üÀº ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î ³ëÀÎ Àα¸°¡ Áõ°¡ÇÏ°í ÀÖ´Â °Íµµ Á¤Çü¿Ü°úÀû ¿¬Á¶Á÷ º¹¿ø ½Ã¼úÀÇ »ç¿ëÀ» Áõ°¡½ÃÅ°´Â ¶Ç ´Ù¸¥ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 10¿ù ¼¼°èº¸°Ç±â±¸(WHO)°¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, 2030³â±îÁö Àü ¼¼°è Àα¸ 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 60¼¼ ÀÌ»ó Àα¸ÀÇ ºñÀ²ÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. 2020³â 10¾ï ¸í¿¡¼ 2030³â¿¡´Â 14¾ï ¸íÀ¸·Î Áõ°¡ÇÏ°í, 2050³â±îÁö Àü ¼¼°è 60¼¼ ÀÌ»ó Àα¸´Â 21¾ï ¸íÀ¸·Î µÎ ¹è·Î ´Ã¾î³¯ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ 80¼¼ ÀÌ»ó Àα¸´Â 2020³â¿¡¼ 2050³â »çÀÌ¿¡ 3¹è Áõ°¡ÇÑ 4¾ï 2,600¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Á¤Çü¿Ü°ú ºÐ¾ßÀÇ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÁÖ¿ä ½ÃÀå ±â¾÷µéµµ ½ÅÁ¦Ç° °³¹ß ¹× Ãâ½Ã¿¡ ´õ¿í ÁýÁßÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Panther Orthopedics, Inc.´Â 2021³â 8¿ù ÀÚ»çÀÇ ¿¬Á¶Á÷ Ç÷§Æû ±â¼úÀÎ PUMA ½Ã½ºÅÛÀÌ Rapidas ¼ö¼ú¿¡ »ç¿ëµÉ °ÍÀ̶ó°í ¹ßÇ¥Çß½À´Ï´Ù. PUMA ½Ã½ºÅÛÀº ÁÖ±âÀûÀÎ ÇÏÁßÀ» »ç¿ëÇÏ¿© °úµµÇÑ ¾ÐÃàÀ̳ª ´À½¼ÇØÁü ¾øÀÌ ¿¬Á¶Á÷À» ¾ÈÁ¤È½ÃÅ°´Â ´ÏƼ³î ±â¹Ý ¿¬Á¶Á÷ °íÁ¤ ÀåÄ¡ÀÔ´Ï´Ù.
µû¶ó¼ ºÎ»ó À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, Á¦Ç° Ãâ½Ã ¼ö Áõ°¡ µî ¾Õ¼ ¾ð±ÞÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Á¶»ç ´ë»ó ºÎ¹®ÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½ºÆ÷Ã÷ ºÎ»óÀÇ Áõ°¡¿Í ´ë±â¾÷ÀÇ ½ÅÁ¦Ç°À¸·Î ÀÎÇØ ºÏ¹Ì°¡ ÁÖ¸ñ¹Þ´Â ½ÃÀå¿¡¼ Å« Á¡À¯À²À» Â÷ÁöÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹Àº ÀÌ Áö¿ª¿¡¼ Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ°í ÀÖÀ¸¸ç, À̴ ÷´Ü ÀÇ·á ½Ã¼³ÀÇ Á¸Àç, ³ëÀÎ Àα¸ÀÇ Áõ°¡, ½ºÆ÷Ã÷ ºÎ»ó ¹ß»ý·ü Áõ°¡, Áö¼ÓÀûÀ¸·Î ³ôÀº ÀÇ·á ºñ¿ëÀ¸·Î ÀÎÇØ ¹Ì±¹ ³» ¿¬Á¶Á÷ º¹¿ø ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â ¹Ì±¹ ±¹°¡¾ÈÀüÀ§¿øȸ°¡ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é 2021³â ¹Ì±¹¿¡¼ ½ºÆ÷Ã÷ ¹× ·¹Å©¸®¿¡ÀÌ¼Ç Àåºñ¿Í °ü·ÃµÈ ºÎ»óÀ¸·Î ÀÀ±Þ½Ç¿¡¼ Ä¡·á¸¦ ¹ÞÀº »ç¶÷Àº ¾à 3,200¸¸ ¸í¿¡ ´ÞÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ºÎ»ó°ú ÀÚÁÖ °ü·ÃµÈ È°µ¿Àº ¿îµ¿, ÀÚÀü°Å Ÿ±â, ³ó±¸¿´½À´Ï´Ù. 2021³â ¹Ì±¹ÀÇ ¿îµ¿ ºÎ»ó·üÀº Àα¸ 10¸¸ ¸í´ç 123.8¸íÀ̾ú½À´Ï´Ù. ÀÚÀü°Å ¹× ¾×¼¼¼¸®´Â 113.7À̾ú½À´Ï´Ù. ³ó±¸ÀÇ °æ¿ì 78.6À̾ú½À´Ï´Ù. ½ºÄÉÀÌÆ®º¸µå, ½ºÄíÅÍ, È£¹öº¸µåÀÇ °æ¿ì 74.2¿´½À´Ï´Ù. Ã౸ÀÇ °æ¿ì 67.2¿´½À´Ï´Ù.
¶ÇÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, ij³ª´Ù Åë°èûÀÌ 2022³â 7¿ù ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é, ij³ª´ÙÀÇ 65¼¼ ÀÌ»ó Àα¸´Â ¾à 7,330,605¸íÀ¸·Î Àüü Àα¸ÀÇ 18.8%¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î Ãß»êµË´Ï´Ù.
ÀÌ Áö¿ª¿¡¼ ½ÅÁ¦Ç° Ãâ½Ã°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¶»ç ´ë»ó ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 8¿ù OSSIO, Inc.´Â OSSEO ¼¶À¯ ºÀÇÕ»ç ¾ÞÄ¿ÀÇ ¹Ì±¹ Ãâ½Ã¿Í ù »ó¾÷Àû »ç¿ëÀ» ½ÃÀÛÇÏ¿© ¹ß/¹ß¸ñ, ¾î±ú, ¹«¸, ¼Õ/¹ß¸ñ, ¼Õ¸ñ, ÆȲÞÄ¡, ÆȲÞÄ¡ ¼ö¼ú¿¡ »ç¿ëµÇ´Â OSSIOÀÇ ¼ºÀåÇÏ°í ÀÖ´Â »ýü ÅëÇÕ ÀÓÇöõÆ® Æ÷Æ®Æú¸®¿À¿¡ ´ëÇÑ È¯ÀÚÀÇ Á¢±Ù¼ºÀ» È®´ëÇß½À´Ï´Ù. ¼Õ/¼Õ¸ñ, ÆȲÞÄ¡ ¼ö¼ú. ÀÌ ÀÓÇöõÆ®´Â OSSIOfiber Áö´ÉÇü »À Àç»ý ±â¼úÀ» »ç¿ëÇÏ¿© ŸÀÇ ÃßÁ¾À» ºÒÇãÇÏ´Â °µµ¿Í Ź¿ùÇÑ ¾ÈÀü¼ºÀ» Á¦°øÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.
µû¶ó¼ ´õ ¸¹Àº Á¦Ç° Ãâ½Ã¿Í Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃá ±¹³» ´Ù¼öÀÇ ½ÃÀå ±â¾÷ÀÇ Á¸Àç, ³ëÀÎ Àα¸ Áõ°¡, ½ºÆ÷Ã÷ °ü·Ã ºÎ»ó ¹ß»ý·ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Á¶»ç ´ë»ó ½ÃÀåÀÇ ¼ºÀåÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿¬Á¶Á÷ ¼öº¹ ½ÃÀåÀº º»ÁúÀûÀ¸·Î Àû´çÈ÷ ÅëÇյǾî ÀÖÀ¸¸ç ¿©·¯ ÁÖ¿ä ±â¾÷À¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ½ÃÀå Á¡À¯À² Ãø¸é¿¡¼ ÇöÀç ÀϺΠ´ë±â¾÷ÀÌ ½ÃÀåÀ» µ¶Á¡ÇÏ°í ÀÖ½À´Ï´Ù. ¿¬±¸¸¦À§ÇÑ ´õ ¸¹Àº Àڱݰú ´õ ³ªÀº À¯Åë ½Ã½ºÅÛÀ» °®Ãá ½ÃÀå ¸®´õ´Â ½ÃÀå¿¡¼ ÀÔÁö¸¦ ±¸ÃàÇß½À´Ï´Ù.
The Global Soft Tissue Repair Market size is estimated at USD 14.78 billion in 2024, and is expected to reach USD 18.80 billion by 2029, growing at a CAGR of 4.93% during the forecast period (2024-2029).
The COVID-19 pandemic had a significant effect on the market initially due to the reduction in the number of soft tissue repair procedures due to lockdown restrictions. For instance, according to an article published by PubMed Central in March 2021, a study was conducted in Poland that showed that the pandemic had substantially impacted the number of dental procedures performed, including dental repair procedures, in the initial phase of the pandemic. However, as the pandemic progressed, the soft tissue repair procedures started to take place normally, which increased the market's growth. For instance, according to an article published by PubMed Central in November 2022, changes were implemented during the pandemic period regarding orthopedic surgeries that proved beneficial after the pandemic subsided and could be potential long-term solutions for optimizing medical orthopedic management. As a result, the pandemic initially had a negative impact on the market under consideration.However, now that the pandemic is over, the market is expected to grow well during the study's forecast period.
The market is expected to grow because of things like the rise in sports-related injuries, the rise in trauma cases, and the rise in the number of older people.
The growing incidence of sports-related injuries is one of the major factors driving market growth, as it is expected to increase the adoption of soft tissue repair procedures. For instance, according to an article published by SpringerLink in September 2022, a study was conducted in Canada in 2022 that showed a high rate of injuries among collision sport participants in Canadian high schools. The study also showed that the rates of injuries ranged from 12.7 injuries per 100 participants every year in rugby to 33.1 injuries per 100 participants every year in ice hockey. The prevalence rate for injuries to the head was 33.3%; for injuries to the wrist or hand, it was 16.0%; for injuries to the shoulder, it was 12.8%; and for injuries to the knee, it was 12.0%.
Furthermore, according to the data published by the National Council on Mental Health in August 2022, it is estimated that 70% of the adult population in the United States has experienced some type of traumatic event at least once in their lives, which is equivalent to 223.4 million people. Because of this, the high number of injuries in the United States is likely to lead to more soft tissue repair procedures.
Moreover, the rising developments by major market players are also expected to enhance the market's growth. For instance, in August 2021, Orthopaedic Implant Company launched its FDA-cleared DRPX wrist fracture plate, which is designed with type II anodized titanium and a low-profile plate and screw design to minimize soft tissue impingement.
Hence, the aforementioned factors, such as the growing incidence of sports-related injuries, the rising trauma cases, and the rising developments by major market players, are expected to enhance the market's growth. However, the high cost of surgical procedures may hinder the growth of the market.
The orthopedics segment is likely to grow at a significant rate during the forecast period. Most of the growth in the orthopedic segment comes from new products, an increasing number of older people, and a lot of soft tissue damage in the joints.
According to an article published by PubMed Central in 2022, a study was conducted in China during the Beijing Olympics 2022, which showed that an estimated 2,897 athletes from 91 countries experienced sports-related injuries or illnesses. The Olympics' medical staff reported 326 injuries and 80 illnesses, equaling 11.3 injuries and 2.8 illnesses per 100 athletes over the 17-day period during the Olympics. Altogether, 11% of the athletes incurred at least one injury, and nearly 3% incurred at least one illness. Thus, the high prevalence of sports injuries is expected to enhance segment growth.
Furthermore, the rising geriatric population around the world is another major factor that is increasing the usage of orthopedic soft tissue repair procedures. For instance, according to the data updated by the WHO in October 2022, it is estimated that by 2030, 1 in 6 people around the world will be aged 60 years or over, and the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030, and by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. It is also predicted that the number of people aged 80 and up will triple between 2020 and 2050, reaching 426 million.
As the orthopedic segment demand grows, major market players are also focusing more on the development of new products and launches, which is boosting the growth of the market. For example, Panther Orthopedics, Inc. announced in August 2021 that its soft tissue platform technology, the PUMA System, would be used in Lapidus surgeries. The PUMA System is a nitinol-based soft tissue fixation device that uses cyclical loading to stabilize soft tissue without over-compression or loosening.
Hence, the aforementioned factors, such as the rising prevalence of injuries, the growing geriatric population, and the rising number of product launches, are expected to boost the growth of the studied segment over the forecast period.
Due to the growing number of sports injuries and new products from big players, North America is likely to have a big share of the market that was looked at.
The United States holds a significant market share in the region, and this is due to the presence of highly advanced medical care facilities, the rising geriatric population, the increasing incidence of sports injuries, and consistently high healthcare expenditure, which is boosting the growth of the soft tissue repair market in the country. For instance, according to the data published by the National Safety Council of the United States in 2021, it is estimated that around 3.2 million people were treated in emergency departments in the United States for injuries involving sports and recreational equipment in 2021. The most common activities that were frequently associated with injuries were exercise, cycling, and basketball. The injury rate for exercise was 123.8 per 100,000 population in the United States in 2021; for bicycles and accessories, it was 113.7; for basketball, it was 78.6; for skateboards, scooters, and hoverboards, it was 74.2; and for football, it was 67.2.
Moreover, the rising geriatric population is also a major factor in market growth. For instance, according to the data published by Statistics Canada in July 2022, it is estimated that around 7,330,605 people are 65 years of age or older in Canada, which accounts for 18.8% of the total population.
The increasing number of new product launches in the region is expected to boost the growth of the studied market. For instance, in August 2022, OSSIO, Inc., initiated the United States launch and first commercial use of OSSEO fiber Suture Anchors, expanding patient access to the company's growing portfolio of bio-integrative implants for use in foot/ankle, shoulder, knee, hand/wrist, and elbow surgery. These implants were designed to achieve unrivaled strength and unmatched safety using their OSSIOfiber Intelligent Bone Regeneration Technology.
Therefore, factors such as the presence of numerous market players in the country focused on more product launches and innovations, the rising geriatric population, and the growing incidence of sports-related injuries are expected to enhance the growth of the studied market over the forecast period.
The Soft Tissue Repair Market is moderately consolidated in nature and consists of several major players. In terms of market share, some of the major players currently dominate the market. Market leaders with more funds for research and a better distribution system have established their positions in the market. Some of the key market players include Arthrex, Inc.; Baxter International, Inc.; Boston Scientific Corporation; Medtronic; and Stryker, among others.